Detalles de la búsqueda
1.
Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3.
Oncologist
; 26(8): e1339-e1346, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34037282
2.
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Semin Cancer Biol
; 52(Pt 2): 16-25, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29024776
3.
Tamoxifen therapy for patients with breast cancer.
Lancet
; 381(9883): 2078, 2013 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23769226
4.
Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node-positive study.
Eur J Cancer
; 114: 76-88, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31075727
5.
Breast Cancer during Pregnancy: An Interdisciplinary Approach in Our Institution.
Breast Care (Basel)
; 7(4): 311-4, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23904834
6.
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6).
Gynecol Oncol
; 105(1): 132-7, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17161453
Resultados
1 -
6
de 6
1
Próxima >
>>